PHE significantly improved the diabetes state in a dose-dependent way by decreasing leptin and increasing GCK, most likely via reducing ROS generation and inflammatory molecules like IL-6 and TNF-α (38). The gene discussed is GCK; the disease is diabetes mellitus.